Capsule shell: HPMC (vegetable)
Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH
For an 8-week protocol , the estimated total usage is about 39.2 mg , which means planning for 4 vials is typically appropriate
Anti-Tumour Research (emerging) Recent publications note BPC-157 exhibits an anti-tumour effect in human melanoma cell lines by inhibiting VEGF's tumour-promoting effects
Product Name: CJC-1295 with DAC Strength: 5mg Chemical Name: Growth Hormone-Releasing Hormone Analogue with Drug Affinity Complex CAS Number: 863288-34-0 Molecular Formula: CHNO Molecular Weight: 3428.01 g/mol Appearance: White to Off-White Lyophilized Powder Classification: Peptide Hormone Analogue Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Growth Hormone Signaling Research Peptide Hormone Analogue Studies Endocrine Pathway Research Store lyophilized material refrigerated at 28C for routine storage
BPC-157 costs approximately $250/month for daily self-injection, with a total protocol cost of $250-750 over 1-3 months